{"title": "Entwicklung der Varizellen-Impfraten und m\u00f6gliche Einflussfaktoren auf die Impfentscheidung der Eltern im Raum M\u00fcnchen in den Jahren 2009\u20132011 nach Einf\u00fchrung der allgemeinen Varizellenimpfung", "author": "C Hagemann; K Seeger; A Kr\u00e4mer; J G Liese; A Streng", "url": null, "hostname": null, "description": "Thieme E-Books & E-Journals", "sitename": "Das Gesundheitswesen", "date": "2017-04-26", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Subscribe to RSS\n[https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000022.xml](https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000022.xml)\nDOI: 10.1055/s-0042-100726\nEntwicklung der Varizellen-Impfraten und m\u00f6gliche Einflussfaktoren auf die Impfentscheidung der Eltern im Raum M\u00fcnchen in den Jahren 2009\u20132011 nach Einf\u00fchrung der allgemeinen VarizellenimpfungVaricella Vaccination Coverage and Possible Factors Influencing Parental Vaccination Decisions in Munich Area 2009\u20132011 after Introduction of Routine Varicella Vaccination\nPublication History\nPublication Date:\n14 April 2016 (online)\nZusammenfassung\nHintergrund und Ziel: Deutschland f\u00fchrte im Jahr 2004 die generelle Varizellenimpfung (VI) f\u00fcr Kinder im Alter von 11\u201314 Monaten ein, seit 2009 mit einer zweiten Dosis im Alter von 15\u201323 Monaten. Mit Einf\u00fchrung des 2-Dosen-Schemas wurde auch in Bayern der zuvor kaum verwendete Kombinationsimpfstoff MMRV erstattungsf\u00e4hig. Wir untersuchten die Impfraten sowie Einflussfaktoren auf die Entscheidung der Eltern zur VI im Raum M\u00fcnchen von 2009 bis 2011 im Rahmen des \u201eBayerischen Varizellen-Surveillance-Projektes\u201c (2006\u20132011).\nMethodik: Querschnittsstudie mit Elternbefragung einer j\u00e4hrlichen Zufallsstichprobe von je 600 Kindern im Alter von 18\u201336 Monaten in M\u00fcnchen, zum Impfstatus des Kindes f\u00fcr Varizellen und Masern, soziodemografischen Faktoren, sowie zur Einstellung der Eltern zur VI.\nErgebnisse: Im Beobachtungszeitraum 2009\u20132011 stiegen die Varizellen-Impfraten f\u00fcr die erste Dosis von 53% (2009) auf 68% (2011) und f\u00fcr die zweite Dosis von 29% (2009) auf 59% (2011). Die zum Vergleich erhobene Masernimpfrate lag 2009\u20132011 bei 88\u201391%. 2009 hatten 51% der geimpften Kinder die Erstimpfung mit dem Kombinationsimpfstoff MMRV erhalten; im Jahr 2011 94% (p<0,001). 2009 bewerteten 27% der Eltern die VI als \u00fcberfl\u00fcssig, dieser Anteil reduzierte sich bis 2011 auf 15%. Die Empfehlung des Kinderarztes war der wichtigste, durchgehend signifikante Einflussfaktor auf die Impfentscheidung (adjustierte OR 11,5; 95%KI 3,6\u201336,3 (2009), 26,7; 95%KI 5,4\u2013132,2 (2010) und 12,7; 95%KI 3,9\u201341,4 (2011)).\nSchlussfolgerung: Die Varizellen-Impfrate (erste Dosis) stieg von 2009 bis 2011 um weitere 15 Prozentpunkte auf 68% an, parallel zur zunehmenden Verwendung von MMRV. Trotz steigender Akzeptanz lag die Varizellen-Erstimpfungsrate jedoch auch 2011 noch deutlich unter der Impfrate f\u00fcr Masern. Die Empfehlung des Kinderarztes zur VI war konsistent in allen Erhebungsjahren der wichtigste Einflussfaktor auf die Impfentscheidung der Eltern. Um m\u00f6gliche negative Effekte, wie einen Anstieg des mittleren Erkrankungsalters zu vermeiden, ist das Erreichen h\u00f6herer Impfraten notwendig. Hierf\u00fcr sind weitere Informationsma\u00dfnahmen f\u00fcr Eltern und Kinder\u00e4rzte dringend erforderlich.\nAbstract\nBackground and Objective: Germany introduced routine varicella vaccination for all infants aged 11\u201314 months in 2004; since 2009, a second dose was recommended for toddlers aged 15\u201323 months. In Bavaria, vaccination with combined MMRV vaccine has been routinely reimbursed since the introduction of the 2-dose vaccination schedule. We investigated varicella vaccination coverage and factors associated with parental acceptance of varicella vaccination in the area of Munich from 2009 to 2011, within the frame of the \u2018Bavarian Varicella Surveillance Project\u2019 (2006\u20132011).\nMethod: Annual cross-sectional parent survey of random samples of 600 children aged 18\u201336 months in Munich on the child\u2019s vaccination status for varicella and measles, socio-demographic data and parental attitude towards varicella vaccination.\nResults: During 2009\u20132011, the first dose varicella vaccination (VV) coverage increased from 53% (2009) to 68% (2011) while the second dose VV increased from 29% (2009) to 59% (2011). First-dose measles vaccination coverage was 88\u201391% (2009\u20132011). In 2009, 51% of all vaccinated children received the combined MMRV vaccine as first dose; in 2011, 94% (p<0.001). In 2009, 27% of all parents considered varicella vaccination as superfluous. This percentage had decreased to 15% by 2011. Recommendation of varicella vaccination by the physician was the most important explanatory factor and was significantly associated with parental acceptance of varicella vaccination in 2009 to 2011 (adjusted OR 11.5; 95%CI 3.6\u201336.3 (2009), 26.7; 95%CI 5.4\u2013132.2 (2010) and 12.7; 95%CI 3.9\u201341.4 (2011)).\nConclusions: From 2009 to 2011, first dose VV coverage further increased by approximately 15% up to 68%, corresponding with the increased use of MMRV. Although parental acceptance had increased, first dose coverage for varicella was still considerably lower than coverage for measles in 2011. Physician\u2019s recommendation of VV was the only independent factor significantly associated with parental acceptance in all study years. A further increase in varicella vaccination coverage is necessary in order to avoid potential negative effects such as an increase in the mean age of children getting infected with varicella. Therefore, information campaigns for both parents and physicians are urgently needed.\n-\nLiteratur\n-\n[1 Robert Koch-Institut . Ratgeber Infektionskrankheiten. 20. Folge: Varizellen, Herpes Zoster. Epidemiol Bull 2000; 46: 365-369]\n-\n[2 Bonanni P, Breuer J, Gershon A et al. Varicella vaccination in Europe \u2013 taking the practical approach. BMC Medicine (2009) 2009; 7 26: 1-12]\n-\n[3 Wagenpfeil S, Neiss A, Banz K et al. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 2004; 10: 425-430]\n-\n[4 Wutzler P, Knuf M, Liese J. Varicella: efficacy of two-dose vaccination in childhood. Dtsch \u00c4rztebl Int 2008; 567-572]\n-\n[5 Liese JG, Grote V, Rosenfeld E et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008; 27: 125-129]\n-\n[6 Rack AL, Grote V, Streng A et al. Neurologic varicella complications before routine immunization in Germany. Pediatr Neurol 2010; 42: 40-48]\n-\n[7 Grote V, Kries R Von, Springer W et al. Varicella-related deaths in children and adolescents \u2013 Germany 2003-2004. Acta Paediatr 2008; 97: 187-192]\n-\n[8 Robert Koch-Institut . Begr\u00fcndung der STIKO f\u00fcr eine allgemeine Varizellenimpfung. Epidemiol Bull 2004; 49: 421-423]\n-\n[9 Robert Koch-Institut . Begr\u00fcndung einer zweiten Varizellenimpfung im Kindesalter. Epidemiol Bull 2009; 32: 328-336]\n-\n[10 Siedler A, Rieck T, Walter D et al. Estimating vaccination coverage in the absence of immunisation registers \u2013 the German experience. Euro Surveill 2012; 17(17):pii=20152 (26.04.2012). Im Internet:] [http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20152](http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20152)Stand: 16.01.2015\n-\n[11 Reuss AM, Feig M, Kappelmayer L et al. Varicella vaccination coverage of children under two years of age in Germany. BMC Public Health 2010; 10: 502]\n-\n[12 Robert Koch-Institut . Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011. Epidemiol Bull 2013; 16: 129-133]\n-\n[13 Streng A, Seeger K, Grote V et al. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004. Vaccine 2010; 28: 5738-5745]\n-\n[14 Streng A, Grote V, Carr D et al. Varicella routine vaccination and the effects on varicella epidemiology \u2013 results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis 2013; 13: 303]\n-\n[15 Bayerisches Landesamt f\u00fcr Statistik und Datenverarbeitung. Regionalstatistik Bayern - Bev\u00f6lkerungsstatistik. M\u00fcnchen; 2006-2012]\n-\n[16 Poethko-M\u00fcller C, Kuhnert R, Schlaud M. Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 851-862]\n-\n[17 Schulz M, Mangiapane S. Masernimpfungen bei Kindern bis zu einem Alter von zwei Jahren. Zentralinstitut f\u00fcr die kassen\u00e4rztliche Versorgung in Deutschland - Versorgungsatlas. Berlin 18.07.2013]\n-\n[18 Robert Koch-Institut . Evaluation der Varizellen-Impfempfehlung durch die STIKO. Stellungnahme der St\u00e4ndigen Impfkommission (STIKO). Epidemiol Bull 2013; 1: 1-5]\n-\n[19 World Health Organisation . The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 1998; 73: 241-248]\n-\n[20 Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveillance: 2010;15(13):pii=19530.] [Im Internet: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19530](http://www.vdek.com/presse/daten/b_versicherte.html)Stand: 04.01.2015 Stand: 04.01.2015\n-\n[21 Marshall GS, Happe LE, Lunacsek OE et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007; 26: 496-500]\n-\n[22 Siedler A, Hecht J, Rieck T et al. Die Varizellenimpfung in Deutschland. Eine Zwischenbilanz mit Blick auf die Masern-Mumps-R\u00f6teln- (MMR-)Impfung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 1313-1320]\n-\n[23 Sch\u00f6nberger K, Ludwig M, Wildner M et al. Timely MMR vaccination in infancy: influence of attitudes and medical advice on the willingness to vaccinate. Klin Padiatr 2012; 224: 437-442]\n-\n[24 Roggendorf H, Freynik P, Hofmann F. Erfolgreiche Strategie zur Verbesserung der Impfraten bei Jugendlichen. Gesundheitswesen (Bundesverband der \u00c4rzte des \u00d6ffentlichen Gesundheitsdienstes (Germany)) 2011; 73: 499-503]\n-\n[25 VDEK \u2013 Verband der Ersatzkassen . Daten zum Gesundheitswesen: Versicherte. Im Internet:] [http://www.vdek.com/presse/daten/b_versicherte.html](http://www.vdek.com/presse/daten/b_versicherte.html)Stand: 04.01.2015\n-\n[26 Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Human Vaccines & Immunotherapeutics 2014; 10: 3594-3600]", "language": null, "image": "https://www.thieme-connect.de/products/static/assets/desktop/img/Twitter_Summary_Default.jpg", "pagetype": null, "links": ["/products/ejournals/abstract/10.1055/s-0042-100726?id=&lang=de", "/products/all/home.html", "/products/ejournals/journals", "/products/ebooks/books", "/products/ebooks/series", "/products/libraryservice", "/products/all/help", "/products/all/contact", "https://www.thieme.de/en/thieme-connect/home-3939.htm", "/products/all/home.html", "#", "#", "#", "#", "#", "javascript:;", "https://www.thieme.de/de/gesundheitswesen/profil-1875.htm", "javascript:;", "https://www.thieme.de/de/gesundheitswesen/autoren-8253.htm", "javascript:;", "https://www.thieme.de/de/gesundheitswesen/Abonnement-31739.htm", "https://www.thieme.de/de/thieme-connect/lizenzierung-18987.htm", "javascript:;", "http://www.kma-online.de/stellenmarkt/", "#", "/products/all/alerts", "/products/all/searchprofiles", "/products/all/settings", "/products/user/logoutWithCentralPage", "/products/user/logoutWithCentralPage", "/products/ejournals/buyDocument", "#", "/products/ejournals/issues/10.1055/s-00000022/2023", "/products/ejournals/issues/10.1055/s-00000022/2022", "/products/ejournals/issues/10.1055/s-00000022/2021", "/products/ejournals/issues/10.1055/s-00000022/2020", "/products/ejournals/issues/10.1055/s-00000022/2019", "/products/ejournals/issues/10.1055/s-00000022/2018", "/products/ejournals/issues/10.1055/s-00000022/2017", "/products/ejournals/issues/10.1055/s-00000022/2016", "/products/ejournals/issues/10.1055/s-00000022/2015", "/products/ejournals/issues/10.1055/s-00000022/2014", "/products/ejournals/issues/10.1055/s-00000022/2013", "/products/ejournals/issues/10.1055/s-00000022/2012", "/products/ejournals/issues/10.1055/s-00000022/2011", "/products/ejournals/issues/10.1055/s-00000022/2010", "/products/ejournals/issues/10.1055/s-00000022/2009", "/products/ejournals/issues/10.1055/s-00000022/2008", "/products/ejournals/issues/10.1055/s-00000022/2007", "/products/ejournals/issues/10.1055/s-00000022/2006", "/products/ejournals/issues/10.1055/s-00000022/2005", "/products/ejournals/issues/10.1055/s-00000022/2004", "/products/ejournals/issues/10.1055/s-00000022/2003", "/products/ejournals/issues/10.1055/s-00000022/2002", "/products/ejournals/issues/10.1055/s-00000022/2001", "/products/ejournals/issues/10.1055/s-00000022/2000", "/products/ejournals/issue/10.1055/s-007-33839", "/products/ejournals/journal/10.1055/s-00000022", "/products/ejournals/sampleIssue/10.1055/s-00000022", "https://www.thieme-connect.de/products/ejournals/journal/10.1055/s-00000021", "https://www.thieme-connect.de/products/ejournals/journal/10.1055/s-00000065", "https://www.thieme.de/shop/c/10010801", "https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000022.xml", "/products/ejournals/ris/10.1055/s-0042-100726/BIB", "#", "#", "#", "#", "mailto:?subject=Recommendation: Das Gesundheitswesen&body=I would like to recommend this article in Das Gesundheitswesen: %0D%0A %0D%0AEntwicklung der Varizellen-Impfraten und m\u00f6gliche Einflussfaktoren auf die Impfentscheidung der Eltern im Raum M\u00fcnchen in den Jahren 2009\u20132011 nach Einf\u00fchrung der allgemeinen Varizellenimpfung %0D%0A %0D%0AAbstract: http://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0042-100726 %0D%0AFull text HTML: http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0042-100726 %0D%0AFull text PDF: http://www.thieme-connect.de/products/ejournals/pdf/10.1055%2Fs-0042-100726.pdf %0D%0A %0D%0AFree sample issue %0D%0Ahttp://www.thieme-connect.de/products/ejournals/sampleIssue/10.1055/s-00000022", "/products/all/alerts", "/products/ejournals/pdf/10.1055/s-0042-100726.pdf", "/products/ejournals/pdf/10.1055/s-0042-100726.pdf", "#", null, "https://eref.thieme.de/10.1055/s-0042-100726", "#abstract", "/products/ejournals/html/10.1055/s-0042-100726", "#references", null, "/products/ejournals/buyDocument/10.1055/s-0042-100726", "javascript:;", "https://www.thieme-connect.de/media/gesu/201704/lookinside/2015-02-018_10-1055-s-0042-100726-1.jpg", null, null, null, null, null, null, null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0001/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Ratgeber Infektionskrankheiten. 20. Folge: Varizellen, Herpes Zoster", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0002/BIB", "https://doi.org/10.1186/1741-7015-7-1", "https://pubmed.ncbi.nlm.nih.gov/19134183", "https://scholar.google.com/scholar_lookup?title=Varicella vaccination in Europe %E2%80%93 taking the practical approach", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0003/BIB", "https://doi.org/10.1111/j.1469-0691.2004.00853.x", "#", "https://scholar.google.com/scholar_lookup?title=Empirical data on the varicella situation in Germany for vaccination decisions", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0004/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Varicella: efficacy of two-dose vaccination in childhood", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0005/BIB", "https://pubmed.ncbi.nlm.nih.gov/18174870", "https://scholar.google.com/scholar_lookup?title=The burden of varicella complications before the introduction of routine varicella vaccination in Germany", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0006/BIB", "https://doi.org/10.1016/j.pediatrneurol.2009.07.012", "https://pubmed.ncbi.nlm.nih.gov/20004861", "https://scholar.google.com/scholar_lookup?title=Neurologic varicella complications before routine immunization in Germany", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0007/BIB", "https://doi.org/10.1111/j.1651-2227.2007.00595.x", "https://pubmed.ncbi.nlm.nih.gov/18076716", "https://scholar.google.com/scholar_lookup?title=Varicella-related deaths in children and adolescents %E2%80%93 Germany 2003-2004", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0008/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Begr%C3%BCndung der STIKO f%C3%BCr eine allgemeine Varizellenimpfung", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0009/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Begr%C3%BCndung einer zweiten Varizellenimpfung im Kindesalter", null, "http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20152", "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0010/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Estimating vaccination coverage in the absence of immunisation registers %E2%80%93 the German experience. Euro Surveill 2012; 17(17):pii=20152 (26.04.2012)", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0011/BIB", "https://doi.org/10.1186/1471-2458-10-502", "https://pubmed.ncbi.nlm.nih.gov/20723217", "https://scholar.google.com/scholar_lookup?title=Varicella vaccination coverage of children under two years of age in Germany", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0012/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2011", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0013/BIB", "https://doi.org/10.1016/j.vaccine.2010.06.007", "https://pubmed.ncbi.nlm.nih.gov/20600490", "https://scholar.google.com/scholar_lookup?title=Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0014/BIB", "https://doi.org/10.1186/1471-2334-13-303", "https://pubmed.ncbi.nlm.nih.gov/23815523", "https://scholar.google.com/scholar_lookup?title=Varicella routine vaccination and the effects on varicella epidemiology %E2%80%93 results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0015/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Regionalstatistik Bayern - Bev%C3%B6lkerungsstatistik", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0016/BIB", "https://doi.org/10.1007/s00103-007-0248-0", "https://pubmed.ncbi.nlm.nih.gov/17514471", "https://scholar.google.com/scholar_lookup?title=Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS)", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0017/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Masernimpfungen bei Kindern bis zu einem Alter von zwei Jahren. Zentralinstitut f%C3%BCr die kassen%C3%A4rztliche Versorgung in Deutschland - Versorgungsatlas", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0018/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Evaluation der Varizellen-Impfempfehlung durch die STIKO. Stellungnahme der St%C3%A4ndigen Impfkommission (STIKO)", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0019/BIB", "https://pubmed.ncbi.nlm.nih.gov/9715106", "https://scholar.google.com/scholar_lookup?title=The WHO position paper on varicella vaccines", null, "http://www.vdek.com/presse/daten/b_versicherte.html", "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0020/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Impact of the routine varicella vaccination programme on varicella epidemiology in Germany", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0021/BIB", "https://doi.org/10.1097/INF.0b013e31805d7f17", "https://pubmed.ncbi.nlm.nih.gov/17529866", "https://scholar.google.com/scholar_lookup?title=Use of combination vaccines is associated with improved coverage rates", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0022/BIB", "https://doi.org/10.1007/s00103-013-1789-z", "https://pubmed.ncbi.nlm.nih.gov/23990095", "https://scholar.google.com/scholar_lookup?title=Die Varizellenimpfung in Deutschland. Eine Zwischenbilanz mit Blick auf die Masern-Mumps-R%C3%B6teln- (MMR-)Impfung", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0023/BIB", "/products/ejournals/abstract/10.1055/s-0032-1321731", "https://pubmed.ncbi.nlm.nih.gov/22821294", "https://scholar.google.com/scholar_lookup?title=Timely MMR vaccination in infancy: influence of attitudes and medical advice on the willingness to vaccinate", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0024/BIB", "/products/ejournals/abstract/10.1055/s-0030-1255085", "https://pubmed.ncbi.nlm.nih.gov/20845266", "https://scholar.google.com/scholar_lookup?title=Erfolgreiche Strategie zur Verbesserung der Impfraten bei Jugendlichen", null, "http://www.vdek.com/presse/daten/b_versicherte.html", "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0025/BIB", "#", "https://scholar.google.com/scholar_lookup?title=Daten zum Gesundheitswesen: Versicherte", null, "/products/ejournals/ris/10.1055/s-0042-100726/id/R2015-02-018-0026/BIB", "https://doi.org/10.4161/hv.34426", "https://pubmed.ncbi.nlm.nih.gov/25483695", "https://scholar.google.com/scholar_lookup?title=Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany", "#top", "https://www.thieme.de/de/thieme-gruppe/Imprint-Thieme-EN.htm", "https://www.thieme.de/de/thieme-gruppe/privacy-policy-statement-Thieme-EN.htm", "/products/"]}